# FDA Inspection 1210113 - Carter Bloodcare - Denton - June 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/carter-bloodcare-denton/5ff5517c-0cbd-4ec9-8358-2d9d8031cc97
Source feed: FDA_Inspections

> FDA Inspection 1210113 for Carter Bloodcare - Denton on June 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210113
- Company Name: Carter Bloodcare - Denton
- Inspection Date: 2023-06-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1066196 - 2018-09-05](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-denton/af742126-6a94-42b8-9c66-5ebd8c816f1f)
- [FDA Inspection 983201 - 2016-08-15](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-denton/b8649342-9a4c-45d7-bfb3-fd302977e558)
- [FDA Inspection 891629 - 2014-07-02](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-denton/0c8b2c42-cda6-4f48-bdcd-2e40e43132fc)
- [FDA Inspection 799644 - 2012-09-20](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-denton/5a8870b0-f7e7-4a23-a307-13bb5ae8bc2e)
- [FDA Inspection 675928 - 2010-08-12](https://www.keypedia.com/records/fda_inspections/carter-bloodcare-denton/88f9c829-5ce1-43f7-99c0-fb0725698444)

Company: https://www.keypedia.com/companies/carter-bloodcare-denton/a761871c-1875-40b0-927d-28aa8b89f188

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d